BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Navarrete C, Garcia-Martin A, DeMesa J, Muñoz E. Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis. Curr Hypertens Rep 2020;22:98. [PMID: 33089434 DOI: 10.1007/s11906-020-01112-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Dörnyei G, Vass Z, Juhász CB, Nádasy GL, Hunyady L, Szekeres M. Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update. Biomedicines 2023;11:306. [DOI: 10.3390/biomedicines11020306] [Reference Citation Analysis]
2 Abd-Nikfarjam B, Dolati-Somarin A, Baradaran Rahimi V, Askari VR. Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases. Biofactors 2023. [PMID: 36637897 DOI: 10.1002/biof.1936] [Reference Citation Analysis]
3 Pinto JS, Martel F. Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review. Clin Drug Investig 2022;42:909-19. [PMID: 36180814 DOI: 10.1007/s40261-022-01205-y] [Reference Citation Analysis]
4 O’rourke R, Lima ML, Jetten J. Healthcare professionals and medical cannabis: a scoping review informed by the theoretical domains framework. J Public Health (Berl ). [DOI: 10.1007/s10389-021-01624-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]